Article
KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Oct 2013
Rekhtman Natasha, Ang Daphne C, Riely Gregory J, Ladanyi Marc, Moreira Andre L
Abstract excerpt
KRAS mutations define a clinically distinct subgroup of lung adenocarcinoma patients, characterized by smoking history, resistance to EGFR-targeted therapies, and adverse prognosis. Whether KRAS-mutated lung adenocarcinomas also have distinct histopathological features is not well established. We tested 180 resected lung adenocarcinomas for KRAS and EGFR mutations by high-sensitivity mass spectrometry-based...
Topics
- Adenocarcinoma
- Adult
- Aged
- Aged, 80 and over
- ErbB Receptors
- Female
- Humans
- Leukocytes
- Lung Neoplasms
- Male
- Middle Aged
